itmn

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Watch for Continued Losses in Shares of ...

Quiksilver (NYSE:ZQK) traded at a new 52-week low today of $1.39. Approximately 1.4 mi ...

Shares of YRC Worldwide Fall Below Previ...

YRC Worldwide (NASDAQ:YRCW) traded at a new 52-week low today of $13.70. This new low ...

Recent 52-Week Low Surpassed in Shares o...

Wynn Resorts (NASDAQ:WYNN) traded today at a new 52-week low of $102.92. So far today ...

Recent 52-Week High Exceeded in Shares o...

Universal Health Services (NYSE:UHS) traded today at a new 52-week high of $131.59. So ...

Shares of Techne Rise Above Previous 52-...

Techne (NASDAQ:TECH) traded at a new 52-week high today of $103.56. So far today appro ...

Skyworks Solutions Looks to Continue to ...

Skyworks Solutions (NASDAQ:SWKS) traded today at a new 52-week high of $106.97. This n ...

Shares of The Inventure Group Fall Below...

Shares of The Inventure Group (NASDAQ:SNAK) traded today at $8.51, breaking its 52-week ...

Watch for Continued Gains in Shares of O...

Shares of Orbotech (NASDAQ:ORBK) traded at a new 52-week high today of $20.41. So far ...

Most Popular Video News